I C U Medical Inc (ICUI) Stock Price, Quote & News

Company Profile

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 949 366 2183

Fax: 949 366 8368

Website: www.icumed.com

Address:

951 Calle Amanecer, San Clemente, United States

Iightning Nov. 26 at 2:36 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $150 Call | Enter: $3.62 Exit: $4.42 | Profit: 21.82% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 12:41 PM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $150 Call | Enter: $3.62 Exit: $4.42 | Profit: 21.82% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 1:36 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $150 Call | Enter: $3.62 Exit: $4.42 | Profit: 21.82% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 10:52 PM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 2:10 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 11:34 PM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 7:50 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

SuperGreenToday Nov. 12 at 5:13 PM

$ICUI Share Price: $140.60 Contract Selected: May 15, 2026 $120 Calls Buy Zone: $25.75 – $31.82 Target Zone: $41.87 – $51.18 Potential Upside: 54% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

JarvisFlow Nov. 7 at 2:46 PM

Keybanc updates rating for ICU Medical ( $ICUI ) to Overweight, target set at 173 → 175.

0 · Reply

JarvisFlow Nov. 7 at 12:50 PM

Piper Sandler has adjusted their stance on ICU Medical ( $ICUI ), setting the rating to Overweight with a target price of 153 → 172.

0 · Reply

ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference

Nov 6, 2025, 7:46 PM EST - 19 days ago

ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 19 days ago

ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

Oct 23, 2025, 8:30 AM EDT - 4 weeks ago

ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call

Sep 10, 2025, 11:04 AM EDT - 2 months ago

ICU Medical, Inc. (ICUI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 21, 2025, 8:30 AM EDT - 3 months ago

ICU Medical to Participate in Upcoming Investor Conferences

Aug 10, 2025, 1:03 AM EDT - 3 months ago

ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 9:15 PM EDT - 3 months ago

ICU Medical (ICUI) Q2 EPS Jumps 40%

Aug 7, 2025, 4:05 PM EDT - 3 months ago

ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

Jul 24, 2025, 8:30 AM EDT - 4 months ago

ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

May 10, 2025, 12:13 PM EDT - 7 months ago

ICU Medical, Inc. (ICUI) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Shareholders to Reach Out

May 8, 2025, 5:30 PM EDT - 7 months ago

ICU Medical, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

May 8, 2025, 4:05 PM EDT - 7 months ago

ICU Medical Announces First Quarter 2025 Results

May 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Shareholders to Learn More About the Investigation

May 7, 2025, 10:00 AM EDT - 7 months ago

ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 6, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Shareholders to Inquire about Securities Investigation

May 5, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Investors to Connect

May 4, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Stockholders to Inquire about Securities Investigation

May 2, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Investors to Learn More About the Investigation

May 1, 2025, 10:00 AM EDT - 7 months ago

ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 1, 2025, 8:30 AM EDT - 7 months ago

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

Apr 30, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Stockholders to Reach Out

Apr 29, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Stockholders to Connect

Apr 28, 2025, 10:00 AM EDT - 7 months ago

ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 28, 2025, 9:02 AM EDT - 7 months ago

ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm

Apr 24, 2025, 8:30 AM EDT - 7 months ago

ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call

Apr 7, 2025, 8:00 AM EDT - 8 months ago

ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps

Mar 24, 2025, 8:30 AM EDT - 8 months ago

ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 7, 2025, 8:40 AM EST - 9 months ago

ICU Medical to Participate at the KeyBanc Healthcare Forum

Feb 27, 2025, 10:57 PM EST - 9 months ago

ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 9 months ago

ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance

Feb 13, 2025, 4:05 PM EST - 10 months ago

ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call

Feb 13, 2025, 4:05 PM EST - 10 months ago

ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference

Jan 3, 2025, 8:30 AM EST - 11 months ago

ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 12, 2024, 8:45 PM EST - 1 year ago

ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:05 PM EST - 1 year ago

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

Nov 6, 2024, 8:30 AM EST - 1 year ago

ICU Medical to Participate at the UBS Global Healthcare Conference

Iightning Nov. 26 at 2:36 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $150 Call | Enter: $3.62 Exit: $4.42 | Profit: 21.82% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 12:41 PM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $150 Call | Enter: $3.62 Exit: $4.42 | Profit: 21.82% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 1:36 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $150 Call | Enter: $3.62 Exit: $4.42 | Profit: 21.82% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 10:52 PM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 2:10 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 11:34 PM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 7:50 AM

1ightning® Options Trade Alert (Actionable) | Buy $ICUI Dec 19 $140 Call | Enter: $6.97 Exit: $12.36 | Profit: 77.21% ROI | https://1ightning.com

0 · Reply

SuperGreenToday Nov. 12 at 5:13 PM

0 · Reply

JarvisFlow Nov. 7 at 2:46 PM

Keybanc updates rating for ICU Medical ( $ICUI ) to Overweight, target set at 173 → 175.

0 · Reply

JarvisFlow Nov. 7 at 12:50 PM

Piper Sandler has adjusted their stance on ICU Medical ( $ICUI ), setting the rating to Overweight with a target price of 153 → 172.

0 · Reply

d_risk Nov. 7 at 12:48 AM

$ICUI - ICU Medical Inc. Common Stock - 10Q - Updated Risk Factors ICUI flags new risks from rising U.S. tariffs on imports from Costa Rica and Mexico, with a national security probe under Section 232 threatening USMCA exemptions and potentially driving up costs. #MedicalDevices #NationalSecurity #SupplyChainCosts #USMCARisks #TradeTariffs 🟢 Added 🟠 Removed https://d-risk.ai/ICUI/10-Q/2025-11-06

0 · Reply

GoodTidings Nov. 4 at 10:55 PM

$ICUI really think Schlorffer should go... Every CEO who R/S ore intends to R/S more than once is not competent for the job... Instead of focusing on increasing sales and onboarding Hospitals this guy is shitting about a vote for R)S... The guy should be ashamed of himself... The easy way out... Screwing shareholders... That's not what shareholders pay for a salary of almost $50000 per month...

0 · Reply

Wolfmat Nov. 4 at 9:55 PM

$ICUI'm out enough of this terrible management

0 · Reply

JarvisFlow Oct. 21 at 1:05 PM

Keybanc has updated their rating for ICU Medical ( $ICUI ) to Overweight with a price target of 173.

0 · Reply

Rolo2024 Sep. 25 at 9:41 PM

$ICUI Great entry point! BUY! BUY! BUY!

0 · Reply

Victory111 Sep. 22 at 10:13 PM

$ICUI believe she is teaching us math.

0 · Reply

CindyRamos192 Sep. 22 at 8:24 AM

$ICUI Healthcare equipment consistency. Steady uptrend intact. Institutional demand steady. Low volatility.

0 · Reply

Noname2022 Sep. 19 at 9:13 PM

$CRMD $ICUI an example of where DEFENCATH could be COMPLEMENTARY to other methods to reduce CLABSI in future population indications

1 · Reply

ScalperGlow Sep. 15 at 10:10 AM

$ICUI Dependent on M&A and market share gains for meaningful upside

0 · Reply

JarvisFlow Sep. 10 at 12:00 PM

Piper Sandler has updated their rating for ICU Medical ( $ICUI ) to Overweight with a price target of 153.

0 · Reply

Estimize Sep. 8 at 1:00 PM

Wall St is expecting 1.43 EPS for $ICUI Q3 [Reporting 11/10 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co

0 · Reply

NVDAMillionaire Sep. 4 at 8:23 AM

$ICUI Brilliant piece that captures ICUI's situation perfectly. So if you want to update your understanding of ICUI or get to know ICUI better, this is essential reading. https://beyondspx.com/quote/ICUI/icu-medical-icui-beyond-integration-leveraging-technology-and-portfolio-optimization-for-margin-expansion#analysis

0 · Reply

Market Cap	3.51B
Revenue (ttm)	2.38B
Net Income (ttm)	-117.69M
EPS (ttm)	N/A
PE Ratio	22.31
Forward PE	24.54
Profit Margin	-4.94%
Debt to Equity Ratio	0.62

Volume	53,238
Avg Vol	280,174
Day's Range	N/A - N/A
Shares Out	24.69M
Stochastic %K	90%
Beta	0.83
Analysts	Strong Sell
Price Target	$176.75